-
EP2322206
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2322206
| EP2322206 - Mutated netrin 1, fragments thereof and uses thereof as drugs [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 22.05.2015 Database last updated on 06.11.2024 | Most recent event Tooltip | 22.05.2015 | Application deemed to be withdrawn | published on 24.06.2015 [2015/26] | Applicant(s) | For all designated states Centre National de la Recherche Scientifique 3, rue Michel-Ange 75016 Paris / FR | For all designated states IVS Institut des Vaisseaux et du Sang Hôpital Lariboisière 2, rue Ambroise Paré 75475 Paris Cedex 10 / FR | [N/P] |
| Former [2011/20] | For all designated states Centre National de la Recherche Scientifique 3, rue Michel-Ange 75016 Paris Cedex 16 / FR | ||
| For all designated states IVS Institut des Vaisseaux et du Sang Hôpital Lariboisière 2, rue Ambroise Paré 75475 Paris Cedex 10 / FR | Inventor(s) | 01 /
Plouët, Jean - décédé / FR | 02 /
Alemany, Monica 14bis, rue du Capitaine Ferber 75020, PARIS / FR | [2011/20] | Representative(s) | Grosset-Fournier, Chantal Catherine, et al Grosset-Fournier & Demachy 54, rue Saint-Lazare 75009 Paris / FR | [N/P] |
| Former [2011/20] | Grosset-Fournier, Chantal Catherine, et al Grosset-Fournier & Demachy 54, rue Saint-Lazare 75009 Paris / FR | Application number, filing date | 10185304.2 | 22.11.2005 | [2011/20] | Priority number, date | FR20040012362 | 22.11.2004 Original published format: FR 0412362 | FR20040012364 | 22.11.2004 Original published format: FR 0412364 | [2011/20] | Filing language | FR | Procedural language | FR | Publication | Type: | A2 Application without search report | No.: | EP2322206 | Date: | 18.05.2011 | Language: | FR | [2011/20] | Type: | A8 Corrected patent application | No.: | EP2322206 | Date: | 04.01.2012 | [2012/01] | Type: | A8 Corrected patent application | No.: | EP2322206 | Date: | 11.04.2012 | [2012/15] | Type: | A3 Search report | No.: | EP2322206 | Date: | 05.06.2013 | Language: | FR | [2013/23] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 08.05.2013 | Classification | IPC: | A61K38/18, C07K14/475, C07K16/22 | [2013/23] | CPC: |
C07K14/475 (EP,US);
A61P1/00 (EP);
A61P17/00 (EP);
A61P17/06 (EP);
A61P19/02 (EP);
A61P19/08 (EP);
A61P21/00 (EP);
A61P25/28 (EP);
A61P27/02 (EP);
A61P27/06 (EP);
A61P27/10 (EP);
A61P29/00 (EP);
A61P3/00 (EP);
A61P3/04 (EP);
A61P3/10 (EP);
A61P35/00 (EP);
A61P35/02 (EP);
A61P37/02 (EP);
A61P43/00 (EP);
A61P9/00 (EP);
A61P9/10 (EP);
|
| Former IPC [2011/20] | A61K38/18, C07K14/475 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2011/20] | Title | German: | Mutiertes Netrin 1, Fragmente davon und ihre Verwendung als Medikamente | [2011/20] | English: | Mutated netrin 1, fragments thereof and uses thereof as drugs | [2011/20] | French: | Nétrine 1 mutée, ses fragments et leur utilisation comme médicaments | [2011/20] | Examination procedure | 05.08.2013 | Examination requested [2013/38] | 02.12.2013 | Amendment by applicant (claims and/or description) | 04.07.2014 | Despatch of a communication from the examining division (Time limit: M06) | 15.01.2015 | Application deemed to be withdrawn, date of legal effect [2015/26] | 10.02.2015 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2015/26] | Parent application(s) Tooltip | EP05820955.2 / EP1814579 | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20050820955) is 11.10.2007 | Fees paid | Renewal fee | 01.10.2010 | Renewal fee patent year 03 | 01.10.2010 | Renewal fee patent year 04 | 01.10.2010 | Renewal fee patent year 05 | 01.10.2010 | Renewal fee patent year 06 | 07.11.2011 | Renewal fee patent year 07 | 26.11.2012 | Renewal fee patent year 08 | 25.11.2013 | Renewal fee patent year 09 | 01.12.2014 | Renewal fee patent year 10 | Penalty fee | Additional fee for renewal fee | 01.10.2010 | 05 M06 Fee paid on 14.12.2013 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]WO9740064 (EXELIXIS PHARMACEUTICALS INC [US], et al) [X] 4,6-11 * the whole document *; | [E]WO2006019904 (UNIV UTHA RES FOUNDATION [US], et al) [E] 4,6-11* examples 2,3,6; claim -; table 1 *; | [XY] - LU X ET AL, "The netrin receptor UNC5B mediates guidance events controlling morphogenesis of the vascular system", NATURE: INTERNATIONAL WEEKLY JOURNAL OF SCIENCE, NATURE PUBLISHING GROUP, UNITED KINGDOM, (20041111), vol. 432, no. 7014, doi:10.1038/NATURE03080, ISSN 0028-0836, pages 179 - 186, XP009054280 [X] 4,6-10 * page 182, line last - page 185 * [Y] 1-3 DOI: http://dx.doi.org/10.1038/nature03080 | [X] - RYUICHI SHIRASAKI ET AL, "Guidance of Circumferentially Growing Axons by Netrin-Dependent and -Independent Floor Plate Chemotropism in the Vertebrate Brain", NEURON, (19961201), vol. 17, no. 6, doi:10.1016/S0896-6273(00)80241-X, ISSN 0896-6273, pages 1079 - 1088, XP055061220 [X] 4,6-10 * page 1086, column r, paragraph 3 * DOI: http://dx.doi.org/10.1016/S0896-6273(00)80241-X | [Y] - KYE WON PARK ET AL, "The axonal attractant Netrin-1 is an angiogenic factor", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, NATIONAL ACADEMY OF SCIENCES, US, (20041116), vol. 101, no. 46, doi:10.1073/PNAS.0405984101, ISSN 0027-8424, pages 16210 - 16215, XP009054278 [Y] 1-3 * the whole document * DOI: http://dx.doi.org/10.1073/pnas.0405984101 | [Y] - THIEBAULT K ET AL, "The netrin-1 receptors UNC5H are putative tumor suppressors controlling cell death commitment", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, NATIONAL ACADEMY OF SCIENCES, US, (20030401), vol. 100, no. 7, doi:10.1073/PNAS.0738063100, ISSN 0027-8424, pages 4173 - 4178, XP002982191 [Y] 1-3 * the whole document * DOI: http://dx.doi.org/10.1073/pnas.0738063100 | by applicant | US2003207347 | - CELERIER J; CRUZ A; LAMANDE N; GASC JM; CORVOL P, "Angiotensinogen and its cleaved derivatives inhibit angiogenesis", HYPERTENSION, (2002), vol. 39, no. 2, pages 224 - 8 | - COOPER HM; GAD JM; KEELING SL, "The Deleted in Colorectal Cancer netrin guidance system: a molecular strategy for neuronal navigation", CLIN EXP PHARMACOL PHYSIOL., (1999), vol. 26, no. 9, pages 749 - 51 | - CORSET V; NGUYEN-BA-CHARVET KT; FORCET C; MOYSE E; CHEDOTAL A; MEHLEN P, "Netrin-1-mediated axon outgrowth and cAMP production requires interaction with adenosine A2b receptor", NATURE, (2000), vol. 407, pages 747 - 50 | - HUTCHINGS H; ORTéGA N; PLOUëT J, "Extracellular matrix bound vascular endothelial growth factor promotes endothelial cell adhesion, migration and survival through integrin ligation", FASEB J., (2003), vol. 17, pages 1520 - 1522 | - INOKI I; SHIOMI T; HASHIMOTO G; ENOMOTO H; NAKAMURA H; MAKINO K; IKEDA E; TAKATA S; KOBAYASHI K; OKADA Y, "Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis", FASEB J., (2002), vol. 16, no. 2, pages 219 - 21 | - JAIN RK; SCHLENGER K; HOCKEL M; YUAN F, "Quantitative angiogenesis assays: progress and problems", NAT MED., (1997), vol. 3, no. 11, pages 1203 - 8 | - KEARNEY JF; RADBRUCH A; LIESEGANG B; RAJEWSKY K, "A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines", J. IMMUNOL., (1979), vol. 123, pages 1548 - 50 | - KUENG W; SILBER E; EPPENBERGER U, "Quantification of cell cultures on 96- well plates", ANAL. BIOCHEM, (1989), vol. 182, no. 1, pages 16 - 9 | - LIVESEY FJ, "Netrins and netrin receptors", CELL MOL LIFE SCI, (1999), vol. 56, no. 1-2, pages 62 - 8 | - LU X; LE NOBLE F; YUAN L; JIANG Q; DE LAFARGE B; SUGIYAMA D; BREANT C; CLAES F; DE SMET F; THOMAS JL, "The netrin receptor UNC5B mediates guidance events controlling morphogenesis ofthe vascular system", NATURE, (2004), vol. 432, pages 179 - 186 | - MATSUNAGA E; TAUSZIG-DELAMASURE S; MONNIER PP; MUELLER BK; STRITTMATTER SM; MEHLEN P; CHEDOTAL A, "RGM and its receptor neogenin regulate neuronal survival", NAT CELL BIOL., (2004), vol. 8, pages 749 - 755 | - MEHLEN P; MAZELIN L, "The dependence receptors DCC and UNC5H as a link between neuronal guidance and survival", BIOL CELL., (2003), vol. 95, no. 7, pages 425 - 36 | - NAKASHIBA T; IKEDA T; NISHIMURA S; TASHIRO K; HONJO T; CULOTTI JG; ITOHARA S, "Netrin-Gl: a novel glycosyl phosphatidylinositol-linked mammalian netrin that is functionally divergent from classical netrins", J NEUROSCI., (2000), vol. 20, no. 17, pages 6540 - 50 | - PAPANIKOLAOU, G; LUDWIG, EH; MACDONALD, ML; FRANCHINI, PL; DUBE, M-P; ANDRES, L; MACFARLANE, J; SAKELLAROPOULOS, N; POLITOU, M; NE, "Mutations in HFE2 cause iron overload in chromosome 1q linked juvenile hemochromatosis", NAT. GENET., (2004), vol. 77-82, no. 36, pages 77 - 82 | - PLOUëT J; MORO F; COLDEBOEUF N; BERTAGNOLLI S; CLAMENS S; BAYARD F, "Extracellular cleavage of the vascular endothelial growth factor 189 aa form by urokinae is required for its mitogenic activity", J. BIOL. CHEM., (1997), vol. 272, pages 13390 - 13396 | - YURCHENCO PD; WADSWORTH WG, "Assembly and tissue functions of early embryonic laminins and netrins", CURR OPIN CELL BIOL., (2004), vol. 16, no. 5, pages 572 - 9 | - ARNAL JF; GOURDY P; GARMY-SUSINI B; DELMAS E; BAYARD F, "Usefulness of experimental models to understand the vascular effects of estrogens", MED SCI (PARIS), (2003), vol. 19, no. 12, pages 1226 - 32 | - BROOKS PC; CLARK RA; CHERESH DA, "Requirement of vascular integrin alpha v beta 3 for angiogenesis", SCIENCE, (1994), vol. 264, pages 569 - 71 | - O'REILLY ET AL., CELL, (1997), vol. 88, pages 277 - 285 | - ORTéGA N; HUTCHINGS H; PLOUëT J, "Signal relays in the VEGF system", FRONT. BIOSC., (1999), vol. 4, pages D141 - D152 |